Literature DB >> 8564529

Release of cytokines from isolated lung strips by bradykinin.

I Paegelow1, H Werner, G Vietinghoff, U Wartner.   

Abstract

Bradykinin as an inflammatory mediator was assayed for its ability to release cytokines from isolated lung tissue derived from guinea pigs, mice and in some cases from patients. Bradykinin elicited in concentrations, which were able to induce a contraction of isolated lung strips, a secretion of different cytokines from the tissue into organ baths as well as from lung tissue incubated in petri dishes (4h, 37 degrees C). Using enzyme immuno assays and the tanned erythrocyte electrophoretic mobility (TEEM)-test in combination with monoclonal antibodies the cytokines could be identified preferably as interleukin(IL)-1, IL-2, sIL-2R and IL-6. Tyrode solution as a control and carbachol in a concentration causing also a contraction were not able to release cytokines in a significant amount. The bradykinin B2 receptor antagonist icatebant (HOE 140) inhibited the bradykinin-induced IL-2 and IL-6 release. The results show that bradykinin can elicit the secretion of the cytokine cascade via a receptor-mediated process.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8564529     DOI: 10.1007/bf02032574

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  31 in total

1.  The bronchoconstrictor action of bradykinin in the guinea-pig.

Authors:  H O COLLIER; J A HOLGATE; M SCHACHTER; P G SHORLEY
Journal:  Br J Pharmacol Chemother       Date:  1960-06

Review 2.  Role of kinins in airway diseases.

Authors:  S G Farmer
Journal:  Immunopharmacology       Date:  1991 Jul-Aug

3.  Bradykinin stimulates tumor necrosis factor and interleukin-1 release from macrophages.

Authors:  C W Tiffany; R M Burch
Journal:  FEBS Lett       Date:  1989-04-24       Impact factor: 4.124

4.  The effect of inhalations of bradykinin on healthy and atopic (asthmatic) children.

Authors:  H S Varonier; R Panzani
Journal:  Int Arch Allergy Appl Immunol       Date:  1968

5.  Modulation of T lymphocyte function by neuropeptides. Evidence for their role as local immunoregulatory elements.

Authors:  D A Nio; R N Moylan; J K Roche
Journal:  J Immunol       Date:  1993-06-15       Impact factor: 5.422

6.  Hyperresponsiveness to autacoids and autonomic drugs in lung parenchymal strips from sensitized guinea pigs.

Authors:  E J Morcillo; M Perpiñá; J Esplugues
Journal:  Am Rev Respir Dis       Date:  1984-06

7.  Thrombin and bradykinin enhance prostaglandin production in human peripheral blood monocytes.

Authors:  U H Lerner; K Sahlberg; O Ljunggren
Journal:  J Oral Pathol Med       Date:  1989-04       Impact factor: 4.253

8.  Interleukin-1 potentiates bradykinin- and TNF alpha-induced PGE2 release.

Authors:  L A O'Neill; G P Lewis
Journal:  Eur J Pharmacol       Date:  1989-07-18       Impact factor: 4.432

Review 9.  TH2 and 'TH2-like' cells in allergy and asthma: pharmacological perspectives.

Authors:  G P Anderson; A J Coyle
Journal:  Trends Pharmacol Sci       Date:  1994-09       Impact factor: 14.819

10.  Effect of interleukin-1 beta on airway hyperresponsiveness and inflammation in sensitized and nonsensitized Brown-Norway rats.

Authors:  H Tsukagoshi; T Sakamoto; W Xu; P J Barnes; K F Chung
Journal:  J Allergy Clin Immunol       Date:  1994-02       Impact factor: 10.793

View more
  9 in total

1.  Bradykinin stimulates NF-kappaB activation and interleukin 1beta gene expression in cultured human fibroblasts.

Authors:  Z K Pan; B L Zuraw; C C Lung; E R Prossnitz; D D Browning; R D Ye
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

2.  Bradykinin stimulates interleukin-8 production by human lung fibroblasts.

Authors:  R Hayashi; N Yamashita; S Matsui; M Maruyama; E Sugiyama; S Sugiyama; M Kobayashi
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

3.  Bradykinin stimulates MMP-2 production in guinea pig tracheal smooth muscle cells.

Authors:  Ewa Zaczynska; Bichoy H Gabra; Pierre Sirois
Journal:  Inflammation       Date:  2003-10       Impact factor: 4.092

4.  A modular map of Bradykinin-mediated inflammatory signaling network.

Authors:  D A B Rex; K Deepak; Neelanchal Vaid; Shobha Dagamajalu; Richard Kumaran Kandasamy; Trude Helen Flo; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2021-10-29       Impact factor: 5.782

5.  PKA and Epac cooperate to augment bradykinin-induced interleukin-8 release from human airway smooth muscle cells.

Authors:  Sara S Roscioni; Loes E M Kistemaker; Mark H Menzen; Carolina R S Elzinga; Reinoud Gosens; Andrew J Halayko; Herman Meurs; Martina Schmidt
Journal:  Respir Res       Date:  2009-09-29

6.  Involvement of steroids in anti-inflammatory effects of PK11195 in a murine model of pleurisy.

Authors:  Marcelo Barreto Spillere da Silva; Roseli Coimbra Farges; Tânia Silvia Fröde
Journal:  Mediators Inflamm       Date:  2004-04       Impact factor: 4.711

7.  Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?

Authors:  Simone Meini; Andrea Zanichelli; Rodolfo Sbrojavacca; Federico Iuri; Anna Teresa Roberts; Chiara Suffritti; Carlo Tascini
Journal:  Front Immunol       Date:  2020-08-11       Impact factor: 7.561

8.  A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.

Authors:  Michael R Garvin; Christiane Alvarez; J Izaak Miller; Erica T Prates; Angelica M Walker; B Kirtley Amos; Alan E Mast; Amy Justice; Bruce Aronow; Daniel Jacobson
Journal:  Elife       Date:  2020-07-07       Impact factor: 8.713

Review 9.  SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy.

Authors:  Mina K Chung; Sadashiva Karnik; Joshua Saef; Cornelia Bergmann; John Barnard; Michael M Lederman; John Tilton; Feixiong Cheng; Clifford V Harding; James B Young; Neil Mehta; Scott J Cameron; Keith R McCrae; Alvin H Schmaier; Jonathan D Smith; Ankur Kalra; Surafel K Gebreselassie; George Thomas; Edward S Hawkins; Lars G Svensson
Journal:  EBioMedicine       Date:  2020-08-06       Impact factor: 8.143

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.